EICHORPublic-registry site landscape for NCT07752979, “Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities”, a Obesity study sponsored by AbbVie. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07752979 (registry record) |
| Study title | Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities |
| Official title | A Phase 2 Dose-Finding Study to Assess the Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities |
| Sponsor | AbbVie |
| Condition(s) | Obesity; Overweight |
| Phase | PHASE2 |
| Listed sites | 0 |
| Intervention(s) | ABBV-295, Placebo |
Patient-friendly overview of this study: eichor.com/study/NCT07752979.
Eichor generates a preliminary site-risk snapshot for NCT07752979 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
